- Home
- ELV vs BMY Comparison
ELV vs BMY Comparison
Compare ELV & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELV
- BMY
- Stock Information
- Founded
- ELV 1944
- BMY 1887
- Country
- ELV United States
- BMY United States
- Employees
- ELV N/A
- BMY N/A
- Industry
- ELV Medical Specialities
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ELV Health Care
- BMY Health Care
- Exchange
- ELV Nasdaq
- BMY Nasdaq
- Market Cap
- ELV 91.2B
- BMY 97.6B
- IPO Year
- ELV N/A
- BMY N/A
- Fundamental
- Price
- ELV $349.00
- BMY $46.99
- Analyst Decision
- ELV Strong Buy
- BMY Hold
- Analyst Count
- ELV 14
- BMY 16
- Target Price
- ELV $512.36
- BMY $58.33
- AVG Volume (30 Days)
- ELV 1.8M
- BMY 14.2M
- Earning Date
- ELV 07-17-2025
- BMY 07-31-2025
- Dividend Yield
- ELV 1.97%
- BMY 5.29%
- EPS Growth
- ELV N/A
- BMY N/A
- EPS
- ELV 25.60
- BMY 2.67
- Revenue
- ELV $183,124,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- ELV $11.19
- BMY N/A
- Revenue Next Year
- ELV $7.29
- BMY N/A
- P/E Ratio
- ELV $13.59
- BMY $17.57
- Revenue Growth
- ELV 6.63
- BMY 4.62
- 52 Week Low
- ELV $347.21
- BMY $39.35
- 52 Week High
- ELV $567.26
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- ELV 33.57
- BMY 44.17
- Support Level
- ELV $370.93
- BMY $46.32
- Resistance Level
- ELV $400.53
- BMY $48.26
- Average True Range (ATR)
- ELV 9.56
- BMY 0.90
- MACD
- ELV -1.45
- BMY -0.01
- Stochastic Oscillator
- ELV 1.18
- BMY 17.48
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.